Welcome to the future of pharmaceutical manufacturing. Collaboration with our partners and customers assures high quality prescription medicines can be made available when and where they are needed. We work with leading pharmaceutical companies to identify business and medical opportunities within new and existing product lines, including life cycle management of marketed products.
For pharmaceutical manufacturers looking to maximize the potential of their R&D pipelines, Aprecia offers the ideal combination of innovative 3DP technology and proven, low-risk strategies to reach the patients you serve.
3DP for Pharma technologies increase sales throughout the drug’s lifecycle by addressing unmet patient needs and expanding the treated patient base.
3DP drug delivery technologies extend brand exclusivity, so that you can keep what you create for a longer period of time.
Adding a sophisticated 3DP drug delivery technology maximizes the innovation value of new therapeutics at launch, while also providing greater patient accessibility through market differentiation.
3DP for Pharma technology enables a new world of powerful formulation solutions for NCE product candidates in Phase I or Phase II.
Aprecia’s 3DP for Pharma technology enables novel dosage forms with new power to help your NCE reach its therapeutic and market potential.
Aprecia’s 3DP-based drug delivery represents the future of pharma, and spans the manufacturing process, from early-stage development through commercial-stage manufacturing and packaging. We put our capabilities to work for you to commercialize your products, bringing them to doctors and patients around the world.
Efficiently manage and execute projects, from feasibility and prototyping through successful regulatory review and commercial launch.
Our experts continuously research new applications for 3DP technology, developing, piloting, scaling and transferring new products for commercial manufacture.
Our in-house regulatory professionals advise and guide you through regulatory filings.
Our products are manufactured in FDA-inspected facilities operating under Current Good Manufacturing Practices (cGMP). Our inspection history includes numerous pre-approval and GMP inspections by FDA.
A dedicated product stability team provides a full range of analytical test method development, validation and sample analysis and timely reporting, adhering to strict compliance and regulatory standards throughout development.
A dedicated Aprecia project manager and development team work with you from feasibility through commercial launch.
Aprecia’s U.S. facilities can meet all of your needs, from clinical supplies through commercial manufacturing.
A dedicated alliance manager works with you to ensure the success of your ongoing program.
From manufacturing clinical supplies to regulatory submissions, Aprecia can lend support to your Phase I/II clinical studies.
Want to learn more about future pharma? Our market insight analysts along with our formulation scientists have identified an extensive list of product candidates ready for co-development.